AFPBristol-Myers to Buy Diabetes Maker Amylin for $5.3 BillionBloombergBristol-Myers (BMY) Squibb Co. agreed to pay $5.3 billion to acquire Amylin Pharmaceuticals Inc. (AMLN), a maker of diabetes therapies, as it seeks to replace revenue from its top-selling blood thinner that's facing generic competition.Bristol-Myers to buy Amylin for about $5.3 billionReutersBristol Will Buy Diabetes Drug MakerWall Street JournalBristol-Myers Squibb to buy Amylin for $7 blnAFPForbes -Moneycontrol.com -Los Angeles Timesall 67 news articles »

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News